Terug

Watch Compare

ONCOLYTICS BIOTECH INC

Datakwaliteit: 83%

ONCY

NASDAQ Manufacturing Chemicals

€ 1,06

▼ € 0,04 (-3,64%)

6 months return

—

Momentum

Neutral

Free cash flow

-20,12 M

Groei

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Kwaliteit

Return on Equity

N/A

ROIC-1532,26%

Net MarginN/A

Op. MarginN/A

Veiligheid

Debt / Equity

N/A

Current Ratio1,12

Interest CoverageN/A

Waardering

PE (TTM|NTM)

-4,12 | -2,99

Onder sectorgemiddelde (-1,50)

P/B RatioN/A

EV/EBITDAN/A

Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -20,12 M

Price History

Financiële Trends

Koersdoel Analisten

6 analisten

Buy

+384.2%

upside to target

Huidig

€ 1,06

Consensus Target

€ 5,13

€ 2,95

Laag

€ 10,07

Hoog

Vooruitzicht

Forward K/W

-2,99

Forward WPA

-€ 0,37

Omzet Sch.

0,0

Winstverassingen

EPS

Reported Estimate Forecast

Next: Q1 2026 · EPS Est: -€ 0,07 · Rev Est: 0,0

	Q12025	Q22025	Q32025	Q42025	Q1 '26	Q2 '26
Reported	-€ 0,08	-€ 0,07	-€ 0,14	—	—	—
Estimate	-€ 0,09	-€ 0,08	-€ 0,07	-€ 0,09	-€ 0,07	-€ 0,08
Verrassing	+11,11%	+17,33%	-108,18%	—	—	—

Growth

Rev 5Y: N/A · Earnings 1Y: N/A

Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A

Profitability

ROE: N/A · Net Margin: N/A

Revenue (TTM)	N/A	Net Income (TTM)	-28,76 M
ROE	N/A	ROA	-379,31%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-20,12 M
ROIC	-1532,26%	FCF Growth (3Y)	N/A

Safety

D/E: N/A · Current: 1,12

Debt / Equity	N/A	Current Ratio	1,12
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	743.000	Tangible Book Value	-3,80 M

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: -4,12 · EV/EBITDA: N/A

P/E Ratio	-4,12	Forward P/E	-2,99
P/B Ratio	N/A	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-16,98%
Market Cap	118,45 M	Enterprise Value	113,25 M

Per Share

EPS: -0,30 · FCF/Share: -0,17

EPS (Diluted TTM)	-0,30	Revenue / Share	N/A
FCF / Share	-0,17	OCF / Share	-0,17
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A

Efficiency

FCF Conv: 69,95% · CapEx/Rev: N/A

CapEx / Revenue	N/A	FCF Conversion	69,95%
SBC-Adj. FCF	-23,22 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025
Revenue	—
Net Income	-28,76 M
EPS (Diluted)	-0,30
Gross Profit	—
Operating Income	-28,73 M
EBITDA	—
R&D Expenses	13,31 M
SG&A Expenses	—
D&A	—
Interest Expense	—
Income Tax	79.000,0

Balance Sheet

Annual, most recent first

Metric	FY2025
Total Assets	7,58 M
Total Liabilities	11,38 M
Shareholders' Equity	-3,80 M
Total Debt	—
Cash & Equivalents	5,20 M
Current Assets	6,84 M
Current Liabilities	6,10 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)

Metriek	Aandeel	Sector Mediaan
P/E	-4,1	-1,5
P/B	—	1,6
ROE %	—	-54,5
Net Margin %	—	-41,5
Rev Growth 5Y %	—	1,8
D/E	—	0,3